Your session is about to expire
← Back to Search
Insulin Management Strategies for Diabetes during Pregnancy
Study Summary
This trial is testing the best way to manage diabetes during pregnancy after a woman has been given a steroid to help her baby's development.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman aged between 18 and 50.You are planning to give birth within 72 hours after receiving the first dose of antenatal corticosteroids.You are between 23 weeks and 36 weeks pregnant.The participant has a major abnormality in the unborn baby.I have type 2 diabetes during or before pregnancy and am on insulin or metformin.It has been over 16 hours since my first dose of antenatal corticosteroids.
- Group 1: Sliding Scale Insulin
- Group 2: Continuous Insulin Infusion
- Group 3: Up-Titration of Home Insulin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people are helping researchers by participating in this clinical trial?
"The clinical trial is recruiting patients, with the original posting on 2/10/2022. Last edited on 3/28/2022, this study is looking for 120 participants from 1 location."
Does this research project restrict participants to a certain age group?
"This particular study is designed for patients that are aged 0-50. Out of the total number 2,696 studies, 414 are for children and 1282 are for senior citizens."
Is there a chance that the Dexcom G6 Professional Continuous Glucose Monitor could hurt patients?
"The Dexcom G6 Professional Continuous Glucose Monitor is a safe medical device, as it has completed Phase 2 clinical trials."
How is the Dexcom G6 Professional Continuous Glucose Monitor used to help patients?
"The Dexcom G6 Professional Continuous Glucose Monitor can be used to treat type 1 diabetes mellitus, diabetic ketoacidosis, and diabetes mellitus."
Is the Dexcom G6 Professional Continuous Glucose Monitor a new device?
"As of now, 86 different research teams are actively studying the Dexcom G6 Professional Continuous Glucose Monitor. Out of these, 15 are in Phase 3 trials. Most of these studies originate from Sao Luis, MA; though, in total, there are 482 locations where research is being conducted on this device."
Are patients still being accepted for this drug trial?
"Yes, this study is still recruiting patients according to the latest update on clinicaltrials.gov. The posting dates for this trial are February 10th 2022 and March 28th 2022 respectively."
How can I enroll in the research trial?
"Eligible participants for this clinical study must have diabetes, be between 0 and 50 weeks gestational age, meet the following maternal criteria: 18-50 years old, and have been hospitalized for antenatal corticosteroid therapy in preparation for preterm birth. A total of 120 individuals are needed."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger